FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...

A randomized phase 2 maintenance strategy with cabozantinib 60 mg daily for up to 2 years failed to improve 4-month PFS versus placebo in high-grade uterine sarcomas. Median PFS was identical at 3.7 ...

To pay almost a million dollars to an unsuccessful job candidate can't help but raise questions about the successful ...

Two former FBI agents have filed a lawsuit alleging that they were fired solely because they were assigned to investigate ...

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.

East Belfast elected rep warns of the rise in "cash-only" purchases of houses being converted to HMOs ...

Titan America S.A. (NYSE:TTAM) Q4 2025 Earnings Call Transcript March 17, 2026 Titan America S.A. misses on earnings expectations. Reported EPS is $0.24 EPS, expectations were $0.2494. Operator: ...

Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...

One-year trial shows AVT05 golimumab biosimilar matches Simponi in rheumatoid arthritis, including switching, with comparable safety and immunogenicity outcomes.

Beach declined to make donor blood transfusion. In formal notation. Like rally point set. Comic casting call. Quad engine plane. Smuggling booze on his gut had been intense to ignore. Afghan daily ...

Chief Executive Officer — Dr. Sergio Traversa Chief Medical Officer, Oncology — Dr. Raj S. Pruthi Chief Financial Officer — Maged S. Shenouda With me on today's call are Relmada Therapeutics, Inc.'s ...